Scientists test 'Living Drug' to reboot immune system in devastating autoimmune conditions
NCT ID NCT06375993
Summary
This is an early-stage study testing a new type of cell therapy called Prula-cel for adults with severe autoimmune diseases that haven't responded well to standard treatments. The therapy involves giving patients specially engineered immune cells designed to target and remove harmful B cells that drive the disease. The main goals are to find a safe dose and see if the treatment can help control these difficult conditions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLEROSIS (SSC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Adicet Clinical Trials
Redwood City, California, 94065, United States
-
Roswell Park Comprehensive Cancer Center
Buffalo, New York, 14263, United States
Conditions
Explore the condition pages connected to this study.